These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16510595)

  • 1. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
    Lee Z; Swaby RF; Liang Y; Yu S; Liu S; Lu KH; Bast RC; Mills GB; Fang X
    Cancer Res; 2006 Mar; 66(5):2740-8. PubMed ID: 16510595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
    Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
    Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
    Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.
    Jeong KJ; Park SY; Seo JH; Lee KB; Choi WS; Han JW; Kang JK; Park CG; Kim YK; Lee HY
    Exp Mol Med; 2008 Dec; 40(6):607-16. PubMed ID: 19116446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites.
    Sako A; Kitayama J; Shida D; Suzuki R; Sakai T; Ohta H; Nagawa H
    J Surg Res; 2006 Jan; 130(1):94-101. PubMed ID: 16171822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells.
    Hurst JH; Henkel PA; Brown AL; Hooks SB
    Cell Signal; 2008 Feb; 20(2):381-9. PubMed ID: 18083345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for tight coupling of Gi protein-mediated lysophosphatidic acid receptor to stimulated cytokine production in ovarian cancer cell.
    Sugiyama M; Imai A; Furui T; Tamaya T
    Am J Obstet Gynecol; 2004 Mar; 190(3):680-5. PubMed ID: 15041999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid stimulates cell growth by different mechanisms in SKOV-3 and Caov-3 ovarian cancer cells: distinct roles for Gi- and Rho-dependent pathways.
    Hurst JH; Hooks SB
    Pharmacology; 2009; 83(6):333-47. PubMed ID: 19420982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells.
    Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Cho M; Suh DS; Yoon MS; Chang CL; Jung JS; Kim JH
    Stem Cells; 2008 Mar; 26(3):789-97. PubMed ID: 18065393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer.
    Wang B; Hendricks DT; Wamunyokoli F; Parker MI
    Cancer Res; 2006 Mar; 66(6):3071-7. PubMed ID: 16540656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.
    Miyamoto S; Hirata M; Yamazaki A; Kageyama T; Hasuwa H; Mizushima H; Tanaka Y; Yagi H; Sonoda K; Kai M; Kanoh H; Nakano H; Mekada E
    Cancer Res; 2004 Aug; 64(16):5720-7. PubMed ID: 15313912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor.
    Chou CH; Wei LH; Kuo ML; Huang YJ; Lai KP; Chen CA; Hsieh CY
    Carcinogenesis; 2005 Jan; 26(1):45-52. PubMed ID: 15471896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
    Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
    J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid regulates blood glucose by stimulating myotube and adipocyte glucose uptake.
    Yea K; Kim J; Lim S; Park HS; Park KS; Suh PG; Ryu SH
    J Mol Med (Berl); 2008 Feb; 86(2):211-20. PubMed ID: 17924084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells.
    Sugimoto N; Takuwa N; Yoshioka K; Takuwa Y
    Exp Cell Res; 2006 Jun; 312(10):1899-908. PubMed ID: 16564043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1.
    Wen Y; Giardina SF; Hamming D; Greenman J; Zachariah E; Bacolod MD; Liu H; Shia J; Amenta PS; Barany F; Paty P; Gerald W; Notterman D
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5951-9. PubMed ID: 17062666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.
    Reinartz S; Lieber S; Pesek J; Brandt DT; Asafova A; Finkernagel F; Watzer B; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Konzer A; Graumann J; Grosse R; Worzfeld T; Müller-Brüsselbach S; Müller R
    Mol Oncol; 2019 Feb; 13(2):185-201. PubMed ID: 30353652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurvival factor for ovarian cancer.
    Kamrava M; Simpkins F; Alejandro E; Michener C; Meltzer E; Kohn EC
    Oncogene; 2005 Oct; 24(47):7084-93. PubMed ID: 16044162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells.
    Sengupta S; Xiao YJ; Xu Y
    FASEB J; 2003 Aug; 17(11):1570-2. PubMed ID: 12824286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells.
    Fang X; Yu S; Bast RC; Liu S; Xu HJ; Hu SX; LaPushin R; Claret FX; Aggarwal BB; Lu Y; Mills GB
    J Biol Chem; 2004 Mar; 279(10):9653-61. PubMed ID: 14670967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.